Literature DB >> 20859700

Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth.

Patrick B White1, Eben M True, Kathryn M Ziegler, Sue S Wang, Deborah A Swartz-Basile, Henry A Pitt, Nicholas J Zyromski.   

Abstract

BACKGROUND: Obesity accelerates development and growth of human pancreatic cancer. We recently reported similar findings in a novel murine model of pancreatic cancer in congenitally obese mice. The current experiments were designed to evaluate the effects of diet-induced obesity on pancreatic cancer growth.
METHODS: Thirty C57BL/6J female mice were fed either control 10% fat (n = 10) or 60% fat diet (n = 20) starting at age 6 weeks. At 11 weeks, 2.5 × 10(5) PAN02 murine pancreatic cancer cells were inoculated. After 6 weeks, tumors were harvested. Serum adiponectin, leptin, insulin, and glucose concentrations were measured. Tumor proliferation, apoptosis, adipocyte content, and tumor-infiltrating lymphocytes were evaluated.
RESULTS: The diet-induced obesity diet led to significant weight gain (control 21.3 ± 0.6 g; diet-induced obesity 23.1 ± 0.5 g; p = 0.03). Mice heavier than 23.1 g were considered "Overweight." Tumors grew significantly larger in overweight (1.3 ± 0.3 g) compared to lean (0.5 ± 0.2 g; p = 0.03) mice; tumor size correlated positively with body weight (R = 0.56; p < 0.02). Serum leptin (3.1 ± 0.7 vs. 1.4 ± 0.2 ng/ml) and insulin (0.5 ± 0.2 vs. 0.18 ± 0.02 ng/ml) were significantly greater in overweight mice. Tumor proliferation, apoptosis, and tumor adipocyte volume were similar. T and B lymphocytes were observed infiltrating tumors from lean and overweight mice in similar number.
CONCLUSION: These data show that diet-induced obesity accelerates the growth of murine pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859700     DOI: 10.1007/s11605-010-1349-x

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  27 in total

Review 1.  Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms.

Authors:  Eugenia E Calle; Rudolf Kaaks
Journal:  Nat Rev Cancer       Date:  2004-08       Impact factor: 60.716

Review 2.  Leptin and cancer.

Authors:  Cecilia Garofalo; Eva Surmacz
Journal:  J Cell Physiol       Date:  2006-04       Impact factor: 6.384

Review 3.  Adipocytokines: mediators linking adipose tissue, inflammation and immunity.

Authors:  Herbert Tilg; Alexander R Moschen
Journal:  Nat Rev Immunol       Date:  2006-09-22       Impact factor: 53.106

4.  The effect of estrone-progesterone treatment on cell proliferation kinetics of hormone-dependent GR mouse mammary tumors.

Authors:  P Janik; P Briand; N R Hartmann
Journal:  Cancer Res       Date:  1975-12       Impact factor: 12.701

5.  Depletion of CD4+CD25+ regulatory T cells promotes a tumor-specific immune response in pancreas cancer-bearing mice.

Authors:  Carsten T Viehl; Todd T Moore; Udaya K Liyanage; Daniel M Frey; Jesmin P Ehlers; Timothy J Eberlein; Peter S Goedegebuure; David C Linehan
Journal:  Ann Surg Oncol       Date:  2006-09-03       Impact factor: 5.344

6.  Hyperphagia and weight gain after gold-thioglucose: relation to hypothalamic neuropeptide Y and proopiomelanocortin.

Authors:  H T Bergen; T M Mizuno; J Taylor; C V Mobbs
Journal:  Endocrinology       Date:  1998-11       Impact factor: 4.736

7.  Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma.

Authors:  Jason B Fleming; Ricardo J Gonzalez; Maria Q B Petzel; E Lin; Jeffrey S Morris; Henry Gomez; Jeffrey E Lee; Christopher H Crane; Peter W T Pisters; Douglas B Evans
Journal:  Arch Surg       Date:  2009-03

8.  Obesity potentiates the growth and dissemination of pancreatic cancer.

Authors:  Nicholas J Zyromski; Abhishek Mathur; Henry A Pitt; Terrence E Wade; Sue Wang; Poornima Nakshatri; Deborah A Swartz-Basile; Harikrishna Nakshatri
Journal:  Surgery       Date:  2009-08       Impact factor: 3.982

9.  Cancer statistics, 2009.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Yongping Hao; Jiaquan Xu; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2009-05-27       Impact factor: 508.702

Review 10.  Leptin in the regulation of immunity, inflammation, and hematopoiesis.

Authors:  G Fantuzzi; R Faggioni
Journal:  J Leukoc Biol       Date:  2000-10       Impact factor: 4.962

View more
  24 in total

Review 1.  The balance between leptin and adiponectin in the control of carcinogenesis - focus on mammary tumorigenesis.

Authors:  Michael E Grossmann; Margot P Cleary
Journal:  Biochimie       Date:  2012-06-20       Impact factor: 4.079

Review 2.  Obesity and cancer: at the crossroads of cellular metabolism and proliferation.

Authors:  Robert W O'Rourke
Journal:  Surg Obes Relat Dis       Date:  2014-08-27       Impact factor: 4.734

3.  Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy.

Authors:  Joao Incio; Hao Liu; Priya Suboj; Shan M Chin; Ivy X Chen; Matthias Pinter; Mei R Ng; Hadi T Nia; Jelena Grahovac; Shannon Kao; Suboj Babykutty; Yuhui Huang; Keehoon Jung; Nuh N Rahbari; Xiaoxing Han; Vikash P Chauhan; John D Martin; Julia Kahn; Peigen Huang; Vikram Desphande; James Michaelson; Theodoros P Michelakos; Cristina R Ferrone; Raquel Soares; Yves Boucher; Dai Fukumura; Rakesh K Jain
Journal:  Cancer Discov       Date:  2016-05-31       Impact factor: 39.397

Review 4.  Diabetes Mellitus and Obesity as Risk Factors for Pancreatic Cancer.

Authors:  Guido Eibl; Zobeida Cruz-Monserrate; Murray Korc; Maxim S Petrov; Mark O Goodarzi; William E Fisher; Aida Habtezion; Aurelia Lugea; Stephen J Pandol; Phil A Hart; Dana K Andersen
Journal:  J Acad Nutr Diet       Date:  2017-09-12       Impact factor: 4.910

Review 5.  The complexities of obesity and diabetes with the development and progression of pancreatic cancer.

Authors:  Bin Bao; Zhiwei Wang; Yiwei Li; Dejuan Kong; Shadan Ali; Sanjeev Banerjee; Aamir Ahmad; Fazlul H Sarkar
Journal:  Biochim Biophys Acta       Date:  2010-12-01

6.  Obesity, but not high-fat diet, promotes murine pancreatic cancer growth.

Authors:  Patrick B White; Kathryn M Ziegler; Deborah A Swartz-Basile; Sue S Wang; Keith D Lillemoe; Henry A Pitt; Nicholas J Zyromski
Journal:  J Gastrointest Surg       Date:  2012-06-12       Impact factor: 3.452

Review 7.  Mechanisms of obesity-induced gastrointestinal neoplasia.

Authors:  José O Alemán; Peter R Holt; Leonardo H Eusebi; Luigi Ricciardiello; Kavish Patidar; Arun J Sanyal
Journal:  Gastroenterology       Date:  2013-12-06       Impact factor: 22.682

8.  Obesity promotes resistance to anti-VEGF therapy in breast cancer by up-regulating IL-6 and potentially FGF-2.

Authors:  Joao Incio; Jennifer A Ligibel; Daniel T McManus; Priya Suboj; Keehoon Jung; Kosuke Kawaguchi; Matthias Pinter; Suboj Babykutty; Shan M Chin; Trupti D Vardam; Yuhui Huang; Nuh N Rahbari; Sylvie Roberge; Dannie Wang; Igor L Gomes-Santos; Stefan B Puchner; Christopher L Schlett; Udo Hoffmman; Marek Ancukiewicz; Sara M Tolaney; Ian E Krop; Dan G Duda; Yves Boucher; Dai Fukumura; Rakesh K Jain
Journal:  Sci Transl Med       Date:  2018-03-14       Impact factor: 17.956

Review 9.  Molecular pathways: adiponectin and leptin signaling in cancer.

Authors:  Michael N Vansaun
Journal:  Clin Cancer Res       Date:  2013-01-25       Impact factor: 12.531

10.  Association analysis of genetic variants of adiponectin gene and risk of pancreatic cancer.

Authors:  Jian-Ping Yang; Xin Li; Feng Wang; Ming Gao; Sheng-Lei Li; Kui-Sheng Chen
Journal:  Int J Clin Exp Med       Date:  2015-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.